Evidence map›Paper›PMID 21285317›Full record

ArticleEndocrinology2011

Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice.

Diane M Jaworski, Olga Sideleva, Holly M Stradecki, Garret D Langlois, Aida Habibovic, Basanthi Satish, William G Tharp, James Lausier, Kyla Larock, Thomas L Jetton and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter?International journal of environmental research and public health · 2020
    Review
  10. Review
  11. Metabolic Phenotype of Wild-Type andEnvironmental health perspectives · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The extracellular matrix and insulin resistance.Trends in endocrinology and metabolism: TEM · 2015
    Review
  20. The cell biology of fat expansion.The Journal of cell biology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Diane M JaworskiDepartment of Anatomy and Neurobiology, University of Vermont College of Medicine, 149 Beaumont Avenue, HSRF 418, Burlington, Vermont 05405, USA. diane.jaworski@uvm.edu
Olga Sideleva
Holly M Stradecki
Garret D Langlois
Aida Habibovic
Basanthi Satish
William G Tharp
James Lausier
Kyla Larock
Thomas L Jetton
Mina Peshavaria
Richard E Pratley
University of Vermont · US

Funding

Proteomics Core for Neuroscience P20 RR16435P20RR016435 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI SPEES, JEFFREY L · 2001 to 2010
$23.5M
TUMOR GROWTH AND METASTASISP30CA022435 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI FOGARTY, JOHN P · 1985 to 2007
$9.6M
Molecular Regulation of TIMP-2 in Neuron Cell CycleR01NS045225 · NINDS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JAWORSKI, DIANE M · 2004 to 2007
$1.4M
Beta cell mass expansion in glucose-infused ratsR01DK068329 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JETTON, THOMAS · 2004 to 2008
$1.4M
NCI NIH HHS P30 CA022435NCI NIH HHS P30 CA22435NCRR NIH HHS P20 RR016435NIDDK NIH HHS DK068329NIDDK NIH HHS R01 DK068329NINDS NIH HHS NS045225NINDS NIH HHS R01 NS045225
6 · The paper itself

Abstract

Circulating levels of matrix metalloproteinases (MMPs) and their endogenous inhibitors, tissue inhibitor of metalloproteinases (TIMPs), are altered in human obesity and may contribute to its pathology. TIMP-2 exerts MMP-dependent (MMP inhibition and pro-MMP-2 activation) and MMP-independent functions. To assess the role of TIMP-2 in a murine model of nutritionally induced obesity, weight gain in wild-type and TIMP-2 deficient [knockout (KO)] mice fed a chow or high-fat diet (HFD) was determined. The effects of diet on glucose tolerance and insulin sensitivity, as well as pancreatic β-cell and adipocyte physiology, were assessed. Chow-fed TIMP-2 KO mice of both sexes became obese but maintained relatively normal glucose tolerance and insulin sensitivity. Obesity was exacerbated on the HFD. However, HFD-fed male, but not female, TIMP-2 KO mice developed insulin resistance with reduced glucose transporter 2 and pancreatic and duodenal homeobox 1 levels, despite increased β-cell mass and hyperplasia. Thus, although β-cell mass was increased, HFD-fed male TIMP-2 KO mice develop diabetes likely due to β-cell exhaustion and failure. TIMP-2 mRNA, whose expression was greatest in sc adipose tissue, was down-regulated in HFD-fed wild-type males, but not females. Furthermore, HFD increased membrane type 1-MMP (MMP-14) expression and activity in male, but not female, sc adipose tissue. Strikingly, MMP-14 expression increased to a greater extent in TIMP-2 KO males and was associated with decreased adipocyte collagen. Taken together, these findings demonstrate a role for TIMP-2 in maintaining extracellular matrix integrity necessary for normal β-cell and adipocyte physiology and that loss of extracellular matrix integrity may underlie diabetic and obesogenic phenotypes.

Indexed as

AdipocytesAdipose TissueAnimalsBlotting, WesternDietary FatsFemaleImmunoenzyme TechniquesInsulin ResistanceInsulin-Secreting CellsLeptinMaleMatrix Metalloproteinase 14MiceMice, KnockoutMicroscopy, ConfocalMicroscopy, FluorescenceDietary FatsLeptinMatrix Metalloproteinase 14Tissue Inhibitor of Metalloproteinase-2

Identifiers

PMID21285317
PMCPMC3060627
OpenAlexW2122428030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.